QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.

Initial Biopsies Miss Many Prostate Cancers

The need for repeat prostate biopsies is a common occurrence in men with elevated PSA levels or a suspicious digital examination whose initial biopsies do not show prostate cancer. Dr. Catalona suggested that with the recent ability to perform a…

Read More
group effort

Prostate Cancer Research Is Group Effort

“I would like to keep our donors informed about the progress of our productive, multi-institutional research group that is recognized by our scientific peers.” William J. Catalona, MD Projects in scientific research are not done by one person anymore. Often,…

Read More

Screening High-Risk Men in Their Forties

African-American men and men with a family history of prostate cancer (particularly those with an affected brother or father) are at higher risk to develop prostate cancer. In high-risk patients, prostate cancer tends to occur at a younger age. Therefore,…

Read More
psa tests

Free PSA Less Helpful for PSA 2.6 to 4

Various components of the PSA Study were featured in presentations for a recent American Urological Association meeting by William J. Catalona, MD; Kimberly Roehl, MPH; and JoAnn Antenor, BS. We thought the QUEST readers would be interested in their findings….

Read More
drcatalona fall2001

Progress in Prostate Cancer Treatment and Research

“Now, we almost never diagnose prostate cancer with distant metastates” Dr. Catalona was the keynote speaker for the Florida Cancer Education Network’s Gala 2001. Other participants included Senator Connie Mack and Senator Bob Dole (via videotape). Dr. Catalona’s speech on…

Read More
takingtheplunge

Latest Developments in Prostate Cancer Treatment

Taking the Information Plunge… Each year, Dr. Catalona presents a course at the American Urological Association Meeting in which he reviews selected articles from the medical literature to update urologists on the latest developments in prostate cancer treatment. We thought…

Read More

Subscribe to Quest

"*" indicates required fields

Email

This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*
Address*